Drawing for EVOC

USPTO serial 79258342

EVOC

Reviewed by CopyMark Law Group

Reg. 6098300Status 700Renewal
Filing date
Status date
Registration date
Jul 14, 2020
Examiner
OAKES, ANNA JENNIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EVOC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Feng Shan

Feng Shan SZDC Law PC1629 K Street NW, Suite 300Washington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded computer software and computer programs to control collection of medical samples by modifying the timing of data collection and to perform analysis of medical samples in connection with and as part of medical apparatus; Downloadable and recorded computer application software for hand-held computing devices, namely, software to control collection of medical samples and to perform analysis of medical samples for use in connection with and as part of medical apparatus and instruments; Downloadable and recorded medical diagnostic software for use to control collection of medical samples and to perform analysis of medical samples in connection with and as part of medical apparatus and instruments; Chemical detection systems and apparatus, namely, analyzers and sampling equipment for use to collect and analyze liquid, solid and gas samples; gas detectors for detecting the presence of gas; Particle counters; Pressure sensors; Downloadable and recorded computer software and computer programs for medical purposes for use to diagnose and monitor diseases in connection with and as part of medical apparatus and instruments; replacement parts and fittings for all of the aforesaid; none of the aforesaid relating to dermatology or skincare; none of the aforesaid relating to vehicles or the automotive industryACTIVE—
010Medical apparatus and instruments for treating cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; Diagnostic apparatus for medical purposes for detecting cancer cells; Chemical detection systems and apparatus for medical purposes, namely, analyzers and sampling equipment for use to collect and analyze liquid, solid and gas samples; Medical imaging apparatus; Medical and clinical devices used for the collection, recording, concentration and analysis of volatile organic compounds in human breath; Medical testing kits in the nature of a medical device for detection of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease for home use; Respiratory equipment for medical purposes; Testing apparatus for medical purposes, namely, breath detectors for use to detect disease biomarkers; Detectors for medical purposes, namely, breath detectors for use to detect disease biomarkers; Sensors for medical purposes, namely, respiratory sensors; Replacement parts and fittings for all of the aforesaid; none of the aforesaid relating to dermatology or skincare; none of the aforesaid goods being related to hip prosthesis or orthopaedic articlesACTIVE—
042Medical research services; Clinical research services in the field of disease biomarkers; Chemical analysis; Chemical research; Analytical laboratory services in the field of disease biomarkers; Biological analysis; Laboratory analysis in the field of disease biomarkers; Scientific laboratory services; Laboratory testing services of disease biomarkers within gas, liquid and solid samples; Medical research laboratory services; Design and development of medical technology and medical apparatus research and development services relating to medical apparatus and instruments; Advice, information and consultancy relating to any of the aforesaid scientific laboratory services; none of the aforesaid relating to dermatology or skincare; none of the aforesaid relating to vehicles or the automotive industryACTIVE—
044Medical services; Consulting services relating to health care; Healthcare services; health advice and information services; Medical care services; Medical clinic services; health clinic services; Medical health assessment services; Health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; Diagnostic health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; providing health information in the form of preparing reports relating to health matters; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic purposes; Genetic testing for medical purposes; advice, information and consultancy services relating to any of the aforesaid medical services; none of the aforesaid relating to dermatology or skincareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 13, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 14, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 21, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 4, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 4, 2020LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 4, 2020FIMPFINAL DISPOSITION PROCESSED—
Oct 14, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 14, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 4, 2020ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 1, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Apr 16, 2020ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 17, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2020GPNXNOTIFICATION PROCESSED BY IB—
Feb 26, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 26, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2020ALIEASSIGNED TO LIE—
Feb 10, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 10, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Feb 10, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 10, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 10, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 10, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Feb 10, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 10, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 10, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 22, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 24, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 24, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 16, 2019RFNTREFUSAL PROCESSED BY IB—
Jul 26, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 26, 2019RFRRREFUSAL PROCESSED BY MPU—
Jul 2, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 1, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
May 10, 2019DOCKASSIGNED TO EXAMINER—
May 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 9, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance